高级检索

    人源化CD33单克隆抗体联合化疗与单用化疗在初次复发或难治性急性髓性白血病治疗中比较的Ⅲ期多中心随机研究的评价

    Assessment of the Phase Ⅲ Randomized Multicenter Study of A Humanized Anti-CD33 Monoclonal Antibody,Lintuzumab, in Combination with Chemotherapy, Versus Chemotherapy alone in Patients with Refractory or First Relapsed Acute Myeloid Leukemia

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回